Table 5.
Comparison of disorders for the ICD-10 assessment period in female subjects
| Migrants | Non-migrants | |||||
|---|---|---|---|---|---|---|
| Disorders (ICD-10) | (n =290) | (n =959) | χ2 CMH | p | p adj | ORMH |
| Hyperkinetic disorders**/*** | 14.5 | 23.6 | 10.1* | 0.0015 | 0.0276 | 0.6 (0.4–0.8) |
| Conduct disorders | 13.8 | 12.9 | 0.03 | n.s. | n.s. | 1.1 (0.7–1.6) |
| Reactions to severe stress**/*** | 31.7 | 14.0 | 44.65 | 0.0000 | 0.0000 | 2.8 (2.1–3.8) |
| Emotional disorders specific to childhood | 4.8 | 9.1 | 5.15 | 0.0233 | 0.3724 | 0.5 (0.3–0.9) |
| Other behavioral and emotional disorders | 4.8 | 4.4 | 0.02 | n.s. | n.s. | 1.1 (0.6–2.0) |
| Pervasive developmental disorders | 7.6 | 4.5 | 4.39 | 0.0361 | 0.5410 | 1.8 (1.1–3.1) |
| Eating disorders | 7.6 | 13.3 | 5.44 | 0.0197 | 0.3346 | 0.6 (0.3–0.9) |
| Mixed disorders of conduct and emotion | 5.5 | 7.5 | 1.18 | n.s. | n.s. | 0.7 (0.4–1.2) |
| Depressive episodes | 6.9 | 9.2 | 1.08 | n.s. | n.s. | 0.7 (0.4–1.2) |
| Personality disorders | 6.9 | 6.8 | 0.01 | n.s. | n.s. | 1.0 (0.6–1.7) |
| Disorders of social functioning | 5.5 | 4.7 | 0.13 | n.s. | n.s. | 1.2 (0.6–2.1) |
| Tic disorders | 0.7 | 0.9 | n.a. | n.a. | n.a. | n.a. |
| Schizophrenia | 3.4 | 2.1 | 1.36 | n.s. | n.s. | 1.7 (0.8–3.7) |
| Obsessive–compulsive disorders | 0.7 | 2.6 | n.a. | n.a. | n.a. | n.a. |
| Disorders due to cannabinoids | 3.4 | 2.0 | 1.36 | n.s. | n.s. | 1.7 (0.8–3.8) |
| Phobic anxiety disorders | 1.4 | 2.8 | n.a. | n.a. | n.a. | n.a. |
| Somatoform disorders | 0.7 | 1.6 | n.a. | n.a. | n.a. | n.a. |
| Mild mental retardation | 2.8 | 0.2 | 14.69 | 0.0001 | 0.0025 | 14.1 (2.9–68.5) |
| Dissociative disorders | 2.8 | 1.0 | 3.51 | n.s. | n.s. | 2.7 (1.1–6.9) |
| Bipolar affective disorders | 2.8 | 0.7 | 6.46 | 0.0110 | 0.1983 | 4.0 (1.4–11.3) |
| Schizoaffective disorders | 2.1 | 0.5 | 4.07 | 0.0437 | 0.6111 | 3.8 (1.2–12.7) |
Data are presented for the total sample for each group (migrants vs. non-migrants) for female subjects (n =number of patients,%). Statistical comparisons for each disorder were performed using the SES-adjusted chi-square (χ2) comparisons. Significant p-values underwent α-adjustment according to the Bonferroni–Holm procedure with adjusted p-values indicated by p adj, while the level of statistical significance remained at p<0.05 (n.a.=not applicable due to low cell frequencies, n.s.=not significant). Data are presented in descending order with respect to the diagnostic frequency of the respective disorders in the total sample. Shaded values represent adjusted and unadjusted significant findings that were also detected for the ICD-9 period of assessment.
Violation of the strata homogeneity prerequisite of the Cochran–Mantel–Haenszel procedure (see text for details).
Significant relationship also found after α-adjustment in males for the ICD-10 period of assessment.
A significant relationship was also found after α-adjustment in males for the ICD-10 period of assessment.